An innovative company focused on the field of ophthalmic gene therapy.
Starry focuses on the field of ophthalmic gene therapy.
T-Capital pays attention to the development of cutting-edge medical technologies such as gene therapy, and helps companies explore long-term development opportunities through professional and industrial resources.
Note: Specific transaction details are subject to public disclosure and project authorization information.
This page describes a representative transaction T-Capital has been involved in. Specific transaction details, amounts, and other terms are subject to public disclosures and authorized information from the parties involved.
If you are considering financing, M&A, divestiture, licensing & business development, or a strategic partnership, we invite you to discuss your project with the T-Capital team.
Contact Us →